Ishares Biotechnology Etf Price History

IBB Etf  USD 137.86  0.88  0.63%   
Below is the normalized historical share price chart for iShares Biotechnology ETF extending back to February 09, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of IShares Biotechnology stands at 137.86, as last reported on the 25th of February, with the highest price reaching 137.86 and the lowest price hitting 137.79 during the day.
3 y Volatility
17.72
200 Day MA
140.4037
1 y Volatility
16.18
50 Day MA
136.1366
Inception Date
2001-02-05
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in IShares Etf, it is important to understand the factors that can impact its price. iShares Biotechnology ETF holds Efficiency (Sharpe) Ratio of -0.0352, which attests that the entity had a -0.0352 % return per unit of risk over the last 3 months. iShares Biotechnology ETF exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out IShares Biotechnology's Market Risk Adjusted Performance of 0.1126, downside deviation of 1.22, and Risk Adjusted Performance of 0.0477 to validate the risk estimate we provide.
  
IShares Etf price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0352

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIBB

Estimated Market Risk

 1.11
  actual daily
9
91% of assets are more volatile

Expected Return

 -0.04
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.04
  actual daily
0
Most of other assets perform better
Based on monthly moving average IShares Biotechnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IShares Biotechnology by adding IShares Biotechnology to a well-diversified portfolio.
Average Mkt Cap Mil
21.8 K

IShares Biotechnology Etf Price History Chart

There are several ways to analyze iShares Biotechnology ETF price data. The simplest method is using a basic IShares candlestick price chart, which shows IShares Biotechnology price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 5, 2025142.33
Lowest PriceDecember 19, 2024131.21

IShares Biotechnology February 25, 2025 Etf Price Synopsis

Various analyses of IShares Biotechnology's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell IShares Etf. It can be used to describe the percentage change in the price of IShares Biotechnology from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of IShares Etf.
IShares Biotechnology Price Daily Balance Of Power(12.57)
IShares Biotechnology Price Action Indicator(0.40)
IShares Biotechnology Price Rate Of Daily Change 0.99 

IShares Biotechnology February 25, 2025 Etf Price Analysis

When benchmark price declines in a down market, there may be an uptick in iShares Biotechnology ETF price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use IShares Biotechnology intraday prices and daily technical indicators to check the level of noise trading in iShares Biotechnology ETF and then apply it to test your longer-term investment strategies against IShares.

IShares Etf Price History Data

The price series of IShares Biotechnology for the period between Wed, Nov 27, 2024 and Tue, Feb 25, 2025 has a statistical range of 11.12 with a coefficient of variation of 2.24. Under current investment horizon, the daily prices are spread out with arithmetic mean of 136.67. The median price for the last 90 days is 137.11. The company completed dividends distribution on 25th of June 2014.
OpenHighLowCloseVolume
02/25/2025
 138.74  137.86  137.79  137.86 
02/24/2025 139.06  140.19  138.72  138.74  798,667 
02/21/2025 140.03  140.72  138.78  138.91  1,258,789 
02/20/2025 139.18  139.61  138.39  139.43  1,439,300 
02/19/2025 137.05  138.83  136.85  138.74  995,890 
02/18/2025 136.91  138.41  136.57  137.11  1,033,897 
02/14/2025 137.29  138.57  136.34  136.55  1,190,690 
02/13/2025 135.83  137.18  134.95  137.04  1,169,170 
02/12/2025 133.31  135.48  133.04  135.47  1,787,027 
02/11/2025 134.79  134.97  133.89  134.24  1,180,426 
02/10/2025 138.07  138.24  135.84  136.15  1,295,800 
02/07/2025 140.33  140.49  137.63  137.67  2,192,064 
02/06/2025 142.73  142.79  140.47  140.56  2,119,951 
02/05/2025 139.65  142.62  139.49  142.33  1,613,363 
02/04/2025 137.55  139.68  136.89  138.81  1,475,500 
02/03/2025 136.55  138.89  136.47  137.85  1,031,800 
01/31/2025 139.04  140.94  138.42  138.66  1,279,300 
01/30/2025 138.28  139.68  137.71  138.87  770,500 
01/29/2025 137.84  138.91  136.54  137.49  1,014,600 
01/28/2025 138.55  139.17  137.49  138.16  1,389,700 
01/27/2025 137.26  139.57  136.98  138.37  1,483,700 
01/24/2025 137.99  138.66  136.98  137.30  1,144,600 
01/23/2025 136.02  138.45  134.64  138.25  2,047,100 
01/22/2025 136.10  137.01  135.74  136.29  1,988,200 
01/21/2025 133.62  136.42  133.53  136.10  1,283,900 
01/17/2025 133.93  134.14  132.61  132.65  1,236,500 
01/16/2025 133.29  133.51  132.06  132.96  1,113,500 
01/15/2025 133.00  134.62  132.50  133.42  2,360,700 
01/14/2025 134.36  134.59  131.22  131.57  2,304,900 
01/13/2025 131.49  134.06  130.81  134.02  1,446,900 
01/10/2025 133.54  133.81  131.76  132.73  2,770,600 
01/08/2025 135.33  135.41  134.16  134.83  1,339,900 
01/07/2025 134.45  137.07  134.45  135.47  1,549,600 
01/06/2025 134.15  135.52  133.81  134.29  1,145,500 
01/03/2025 133.17  134.75  132.89  134.15  840,900 
01/02/2025 132.94  134.06  132.36  132.91  1,077,000 
12/31/2024 132.06  133.06  131.37  132.21  1,334,500 
12/30/2024 132.32  132.65  130.98  131.67  1,035,200 
12/27/2024 133.74  134.90  132.74  133.52  838,900 
12/26/2024 133.36  134.81  132.90  134.67  879,900 
12/24/2024 133.58  134.02  132.50  133.95  462,800 
12/23/2024 132.37  133.75  131.97  133.61  1,624,000 
12/20/2024 130.73  134.02  130.51  132.73  1,998,600 
12/19/2024 131.13  132.04  129.61  131.21  2,418,800 
12/18/2024 137.61  137.96  131.67  132.32  2,210,798 
12/17/2024 136.71  138.67  136.47  137.66  2,653,305 
12/16/2024 136.86  138.48  136.18  137.19  1,510,373 
12/13/2024 137.12  137.59  135.78  136.55  1,400,321 
12/12/2024 139.20  139.68  137.52  137.61  1,492,404 
12/11/2024 140.48  141.26  139.37  140.04  1,033,891 
12/10/2024 141.51  142.05  140.16  140.50  1,281,635 
12/09/2024 141.61  142.78  141.29  141.68  1,255,813 
12/06/2024 140.32  142.17  140.18  141.24  1,627,413 
12/05/2024 140.54  141.06  139.52  139.89  751,090 
12/04/2024 139.86  141.43  139.18  140.90  1,304,523 
12/03/2024 141.87  141.87  139.79  139.94  1,136,586 
12/02/2024 141.30  142.15  140.94  141.67  991,148 
11/29/2024 142.11  142.11  140.92  141.49  1,585,134 
11/27/2024 140.65  141.84  140.34  141.53  1,151,087 
11/26/2024 138.77  140.33  137.37  140.17  1,800,970 
11/25/2024 139.47  141.04  139.31  139.85  3,320,201 

About IShares Biotechnology Etf history

IShares Biotechnology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for IShares is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in iShares Biotechnology ETF will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing IShares Biotechnology stock prices may prove useful in developing a viable investing in IShares Biotechnology
The fund generally will invest at least 80 percent of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20 percent of its assets in certain futures, options and swap contracts, cash and cash equivalents. Nasdaq Biotechnology is traded on NASDAQ Exchange in the United States.

IShares Biotechnology Etf Technical Analysis

IShares Biotechnology technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
A focus of IShares Biotechnology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of IShares Biotechnology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Stock Screener Now

   

Stock Screener

Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
All  Next Launch Module

IShares Biotechnology Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for IShares Biotechnology's price direction in advance. Along with the technical and fundamental analysis of IShares Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of IShares to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether iShares Biotechnology ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IShares Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ishares Biotechnology Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ishares Biotechnology Etf:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Biotechnology ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
The market value of iShares Biotechnology ETF is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is IShares Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Biotechnology's market value can be influenced by many factors that don't directly affect IShares Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.